Joris Jan Heus

Title: Joris Jan Heus: Innovator in Transgenic Technology

Introduction

Joris Jan Heus is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human mammals for medical applications. With a total of 2 patents, his work focuses on innovative solutions for treating genetic disorders.

Latest Patents

One of his latest patents is titled "C1 Inhibitor produced in the milk of transgenic non-human mammals." This invention provides transgenic non-human mammals that express C1 inhibitor in their milk, which is beneficial for treating patients with hereditary angioedema or those requiring immunosuppression. Another significant patent is related to "Human acid alpha glucosidase gene and bovine alpha-S1 casein gene sequences." This invention offers polynucleotide sequences from the human acid alpha glucosidase gene and the bovine alpha S1 casein gene, which are useful for designing transgenes for the expression of human acid alpha glucosidase in the milk of transgenic animals.

Career Highlights

Throughout his career, Joris Jan Heus has worked with prominent companies in the biotechnology sector, including Pharming Intellectual Property B.V. and Genzyme Corporation. His expertise in transgenic technology has positioned him as a key figure in the development of innovative medical treatments.

Collaborations

He has collaborated with notable colleagues such as Jan Henricus Nuijens and Henricus Antonius Van Veen, contributing to advancements in the field through shared knowledge and expertise.

Conclusion

Joris Jan Heus is a pioneering inventor whose work in transgenic technology has the potential to transform medical treatments for genetic disorders. His patents reflect a commitment to innovation and improving patient care through biotechnology.